pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Obesity · news · pharmadog
← back to Obesity
News mentioning Obesity
737
stories
Sep 15, 26
STAT+: Obesity drugmakers are testing in kids as young as 6
stat
Sep 15, 26
Businesses can now apply for NIH funding
stat
Sep 15, 26
Novo walks away from $285M pact to develop monthly GLP-1 obesity drug with Ascendis
fiercebiotech
Sep 14, 26
Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand
biospace
Sep 14, 26
Lilly cans early experimental obesity drug after ‘high bar’ not met
fiercebiotech
Sep 14, 26
STAT+: Definium’s LSD therapy eased anxiety in second large trial
stat
Sep 14, 26
Corbus posts phase 1 obesity data for drug mechanism that defeated Novo, Sanofi
fiercebiotech
Sep 14, 26
STAT+: What’s in a name? Novo looks to a rebrand
stat
Sep 14, 26
Cyclic peptides open new drug frontiers, if manufacturing can keep up
biospace
Sep 14, 26
No more Nordisk as Novo goes it alone amid rebranding push
fiercebiotech
Sep 11, 26
This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree
biopharma dive
Sep 11, 26
Samsung Biologics inks $262M manufacturing deal with European pharma company
biospace
Sep 11, 26
Frazier adds $1.1B+ to small and mid-sized biotech fund
biospace
Sep 10, 26
Why two promising heart drugs flopped and what’s next
stat
Sep 10, 26
Encoded raises $275M series F for Dravet syndrome gene therapy
biospace
Sep 9, 26
Mass. governor makes pre-election pitch to biotechs amid warning early-stage start-ups are 'dying'
fiercebiotech
Sep 9, 26
Webinar: The Massive Scale of GLP-1s: Evolving Health, Healthcare and Markets
biospace
Sep 9, 26
STAT+: Orexin discoverers awarded prestigious Lasker award
stat
Sep 9, 26
Steady stream of crossover rounds stock biotech's IPO pipeline
biospace
Sep 8, 26
Moonwalk reloads with $70M and new RNAi prospects for obesity
biopharma dive
Sep 8, 26
Schrödinger births new immunology and inflammation biotech, Tectora Therapeutics
fiercebiotech
Sep 8, 26
Krazati withdrawal completed; Wegovy trial meets endpoint for kids ages 6 to 12
endpoints
Sep 8, 26
Structure’s obesity portfolio impresses on GLP-1 and amylin fronts in dual data drop
biospace
Sep 8, 26
Novo shutters 2 more heart disease studies, indicating IL-6 is ‘invalid target’
biospace
Sep 8, 26
STAT+: FDA approves AstraZeneca breast cancer drug
stat
Sep 8, 26
Moonwalk pulls in $70M to take fat-targeting RNAi obesity candidate to clinic
biospace
Sep 8, 26
Moonwalk raises $70M to test siRNA treatment for obesity
endpoints
Sep 8, 26
An administrative gap delays access to new pancreatic cancer treatment
stat
Sep 8, 26
Opinion: I’m a fat medical student. I refuse to let myself be shamed for it
stat
Sep 7, 26
Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped
fiercebiotech
← prev
page 11 of 25
next →